ASO Author Reflections: Treatment Choice for Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical Prostatectomy

Ann Surg Oncol. 2024 Jun;31(6):3906-3907. doi: 10.1245/s10434-024-15088-0. Epub 2024 Feb 19.

Authors

Masaki Shiota¹, Takahiro Kimura², Naotaka Nishiyama³, Hiroshi Kitamura³, Masatoshi Eto⁴; Japanese Urological Oncology Group

Affiliations

¹ Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. shiota.masaki.101@m.kyushu-u.ac.jp.
² Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
³ Department of Urology, University of Toyama, Toyama, Japan.
⁴ Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

PMID: 38372867
DOI: 10.1245/s10434-024-15088-0

No abstract available

MeSH terms

Humans
Lymph Nodes / pathology
Lymph Nodes / surgery
Lymphatic Metastasis
Male
Prognosis
Prostate-Specific Antigen* / blood
Prostatectomy* / methods
Prostatic Neoplasms* / pathology
Prostatic Neoplasms* / surgery

Substances

Prostate-Specific Antigen